Are Analysts Bearish Perrigo Company plc (NYSE:PRGO) After Last Week?

September 16, 2018 - By Vernon Prom

Perrigo Company plc (NYSE:PRGO) LogoInvestors sentiment increased to 1.18 in Q2 2018. Its up 0.30, from 0.88 in 2018Q1. It increased, as 36 investors sold Perrigo Company plc shares while 104 reduced holdings. 47 funds opened positions while 118 raised stakes. 105.75 million shares or 2.70% more from 102.96 million shares in 2018Q1 were reported.
Gateway Investment Advisers Ltd Liability holds 0% in Perrigo Company plc (NYSE:PRGO) or 5,905 shares. Cooke Bieler Lp invested 0.22% of its portfolio in Perrigo Company plc (NYSE:PRGO). Cibc Asset Management Incorporated reported 0% stake. Brinker Capital stated it has 8,236 shares or 0.02% of all its holdings. Moreover, Toronto Dominion Natl Bank has 0.01% invested in Perrigo Company plc (NYSE:PRGO). Td Asset Management reported 0% stake. Regions Fin Corp, Alabama-based fund reported 12 shares. Caisse De Depot Et Placement Du Quebec has 41,021 shares for 0.01% of their portfolio. Blackrock stated it has 8.83 million shares or 0.03% of all its holdings. Copeland Capital Mngmt Ltd Liability accumulated 124,825 shares. Moreover, Fincl Architects has 0% invested in Perrigo Company plc (NYSE:PRGO). Putnam Invests Limited Liability Co has 41,012 shares. 65,360 were accumulated by Goodman Fincl. Poplar Forest Limited Liability Corporation owns 14,625 shares for 0.09% of their portfolio. Korea Investment has 1,331 shares for 0% of their portfolio.

Perrigo Company plc (NYSE:PRGO) Ratings Coverage

Among 9 analysts covering Perrigo Company plc (NYSE:PRGO), 1 have Buy rating, 1 Sell and 7 Hold. Therefore 11% are positive. Perrigo Company plc had 11 analyst reports since May 8, 2018 according to SRatingsIntel. The stock has “Hold” rating by Deutsche Bank on Friday, August 10. The stock has “Buy” rating by Cantor Fitzgerald on Tuesday, May 8. The firm has “Sector Perform” rating given on Friday, August 10 by RBC Capital Markets. As per Wednesday, June 6, the company rating was downgraded by Barclays Capital. The rating was downgraded by Goldman Sachs to “Sell” on Thursday, July 12. As per Monday, May 14, the company rating was maintained by Cantor Fitzgerald. The rating was downgraded by Argus Research on Monday, July 30 to “Hold”. The firm has “Market Perform” rating by Wells Fargo given on Tuesday, August 21. JP Morgan maintained it with “Neutral” rating and $75 target in Friday, August 10 report. Wells Fargo maintained the shares of PRGO in report on Monday, May 14 with “Market Perform” rating. Below is a list of Perrigo Company plc (NYSE:PRGO) latest ratings and price target changes.

21/08/2018 Broker: Wells Fargo Old Rating: Market Perform New Rating: Market Perform Old Target: $84 New Target: $77 Maintain
10/08/2018 Broker: RBC Capital Markets Old Rating: Sector Perform New Rating: Sector Perform Old Target: $89 New Target: $67 Maintain
10/08/2018 Broker: JP Morgan Old Rating: Neutral New Rating: Neutral Old Target: $83 New Target: $75 Maintain
10/08/2018 Broker: Deutsche Bank Old Rating: Buy New Rating: Hold Old Target: $93 New Target: $78 Downgrade
30/07/2018 Broker: Argus Research Old Rating: Buy New Rating: Hold Downgrade
12/07/2018 Broker: Goldman Sachs Old Rating: Neutral New Rating: Sell Old Target: $78 New Target: $74 Downgrade
18/06/2018 Broker: Morgan Stanley Rating: Hold New Target: $85.0000
06/06/2018 Broker: Barclays Capital Old Rating: Overweight New Rating: Equal-Weight Old Target: $110 Downgrade
14/05/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $107.0000 Maintain
14/05/2018 Broker: Wells Fargo Old Rating: Market Perform New Rating: Market Perform Old Target: $90 New Target: $84 Maintain

The stock decreased 2.44% or $1.84 during the last trading session, reaching $73.69. About 1.58M shares traded or 10.23% up from the average. Perrigo Company plc (NYSE:PRGO) has declined 15.60% since September 16, 2017 and is downtrending. It has underperformed by 31.22% the S&P500.

Perrigo Company plc, together with its subsidiaries, develops, makes, markets, and distributes over-the-counter consumer goods and pharmaceutical products worldwide. The company has market cap of $10.08 billion. It offers OTC products in various categories, including cough, cold, allergy and sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic products, natural health and vitamins, personal care and derma-therapeutics, lifestyle, and anti-parasite; consumer healthcare products; and vitamins, minerals, and supplements. It has a 44.1 P/E ratio. The firm also provides generic and specialty pharmaceutical prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, oral solid dosage forms, and oral liquid formulations.

Another recent and important Perrigo Company plc (NYSE:PRGO) news was published by Benzinga.com which published an article titled: “Health Care Has Been On Fire. Will The Uptrend Continue?” on September 07, 2018.

Perrigo Company plc (NYSE:PRGO) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.